
Vol. 67, Suppl. 1, 2007
Free Abstract
Article (Fulltext)
Article (PDF 103 KB)
Growth Hormone and Growth Factors in Endocrinology and Metabolism. Editor(s): Koppeschaar, H.P.F. (Utrecht), Tuvemo, T. (Uppsala), Trainer, P. (Manchester), Zeitler, P. (Denver, Colo.)
Pediatric Clinical Case Sessions
Hepatic Enzyme Abnormalities in Turner Syndrome: A Case Report
P. Pervanidou, P. Xekouki, C. Dacou-Voutetakis
First Department of Pediatrics, Division of Endocrinology, Metabolism and Diabetes, University of Athens, 'Aghia Sophia' Children's Hospital, Athens, Greece
Address of Corresponding Author
Horm Res 2007;67 (Suppl. 1):106-108 (DOI: 10.1159/000097563)
Key Words
- Turner syndrome
- Hepatic enzymes
- Hormone replacement therapy
- Growth hormone
- Liver
Abstract
Background: Liver dysfunction has been described in subjects with Turner syndrome. The mechanism involved is not known. Methods: Using appropriate methodology, we evaluated the hepatic enzymes serum glutamic-oxaloacetic transaminase, serum glutamic pyruvic transaminase and -glutamyl transpeptidase ( -GT) in a girl with 45 XO/46 Xr mosaic karyotype. She was monitored from age 9 to 20 years while she underwent various therapeutic regimens. Results: Serum glutamic-oxaloacetic transaminase, serum glutamic pyruvic transaminase and particularly -GT concentrations ranged from normal to elevated values during human growth hormone therapy, estrogen replacement therapy (conjugated estrogens were replaced after 1 year with transdermal estrogens and medroxyprogesterone), and periods without therapy. The type of the therapeutic regimen did not seem to influence the hepatic enzyme values. A correlation was found between -GT values and body mass index (BMI). Conclusions: In our patient the waxing and waning of the liver enzymes was not influenced by the therapeutic regimen, but -GT seemed to correlate with BMI. Copyright © 2007 S. Karger AG, Basel
Author Contacts Panagiota Pervanidou, MD University of Athens, 'Aghia Sophia' Children's Hospital First Department of Pediatrics, Division of Endocrinology, Metabolism and Diabetes 26 Charavgis Str., Athens, Chalandri 152 32 (Greece) Tel. +30 210 683 3936, Fax +30 210 652 5013, E-Mail ppervanid@med.uoa.gr
Article Information
Published online: February 15, 2007
Number of Print Pages : 3
Number of Figures : 2, Number of Tables : 0, Number of References : 13 |
|

|

For non-native English speakers and international authors who would like assistance with their writing before submission, we suggest American Journal Experts for their scientific editing service. |
|
|